204 related articles for article (PubMed ID: 28976934)
1. Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.
Tur MK; Daramola AK; Gattenlöhner S; Herling M; Chetty S; Barth S
Biomedicines; 2017 Oct; 5(4):. PubMed ID: 28976934
[TBL] [Abstract][Full Text] [Related]
2. A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells.
Lilienthal N; Lohmann G; Crispatzu G; Vasyutina E; Zittrich S; Mayer P; Herling CD; Tur MK; Hallek M; Pfitzer G; Barth S; Herling M
Mol Cancer Ther; 2016 May; 15(5):971-84. PubMed ID: 26826117
[TBL] [Abstract][Full Text] [Related]
3. Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells.
Tur MK; Neef I; Jost E; Galm O; Jäger G; Stöcker M; Ribbert M; Osieka R; Klinge U; Barth S
J Immunother; 2009 Jun; 32(5):431-41. PubMed ID: 19609235
[TBL] [Abstract][Full Text] [Related]
4. Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy.
Tur MK; Neef I; Jäger G; Teubner A; Stöcker M; Melmer G; Barth S
Curr Pharm Des; 2009; 15(23):2693-9. PubMed ID: 19689339
[TBL] [Abstract][Full Text] [Related]
5. Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals.
Elbadawy M; Usui T; Yamawaki H; Sasaki K
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287790
[TBL] [Abstract][Full Text] [Related]
6. Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells.
Mungra N; Jordaan S; Hlongwane P; Naran K; Chetty S; Barth S
Oncotarget; 2019 Jan; 10(8):897-915. PubMed ID: 30783518
[TBL] [Abstract][Full Text] [Related]
7. Death-associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes.
Farag AK; Roh EJ
Med Res Rev; 2019 Jan; 39(1):349-385. PubMed ID: 29949198
[TBL] [Abstract][Full Text] [Related]
8. Death-associated protein kinases and intestinal epithelial homeostasis.
Chen HM; MacDonald JA
Anat Rec (Hoboken); 2023 May; 306(5):1062-1087. PubMed ID: 35735750
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Non-coding RNAs for Death Associated Protein Kinase Family.
Wang Q; Lin Y; Zhong W; Jiang Y; Lin Y
Front Mol Biosci; 2021; 8():649100. PubMed ID: 34422899
[TBL] [Abstract][Full Text] [Related]
10. Human Granzyme B Based Targeted Cytolytic Fusion Proteins.
Hlongwane P; Mungra N; Madheswaran S; Akinrinmade OA; Chetty S; Barth S
Biomedicines; 2018 Jun; 6(2):. PubMed ID: 29925790
[TBL] [Abstract][Full Text] [Related]
11. DAPK2 regulates oxidative stress in cancer cells by preserving mitochondrial function.
Schlegel CR; Georgiou ML; Misterek MB; Stöcker S; Chater ER; Munro CE; Pardo OE; Seckl MJ; Costa-Pereira AP
Cell Death Dis; 2015 Mar; 6(3):e1671. PubMed ID: 25741596
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
13. Structure of the dimeric autoinhibited conformation of DAPK2, a pro-apoptotic protein kinase.
Patel AK; Yadav RP; Majava V; Kursula I; Kursula P
J Mol Biol; 2011 Jun; 409(3):369-83. PubMed ID: 21497605
[TBL] [Abstract][Full Text] [Related]
14. Death-associated protein kinase 2: Regulator of apoptosis, autophagy and inflammation.
Geering B
Int J Biochem Cell Biol; 2015 Aug; 65():151-4. PubMed ID: 26055515
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling.
Anjum R; Roux PP; Ballif BA; Gygi SP; Blenis J
Curr Biol; 2005 Oct; 15(19):1762-7. PubMed ID: 16213824
[TBL] [Abstract][Full Text] [Related]
17. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Aberg M; Johnell M; Wickström M; Siegbahn A
Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
[TBL] [Abstract][Full Text] [Related]
18. Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation.
Bochicchio A; Jordaan S; Losasso V; Chetty S; Perera RC; Ippoliti E; Barth S; Carloni P
Biomedicines; 2017 Feb; 5(1):. PubMed ID: 28536352
[TBL] [Abstract][Full Text] [Related]
19. Interactions of calmodulin with death-associated protein kinase peptides: experimental and modeling studies.
Kuczera K; Kursula P
J Biomol Struct Dyn; 2012; 30(1):45-61. PubMed ID: 22571432
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.
Yan C; Li S; Li Z; Peng H; Yuan X; Jiang L; Zhang Y; Fan D; Hu X; Yang M; Xiong D
Mol Pharm; 2013 Jan; 10(1):142-51. PubMed ID: 23121392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
